LAMATTINA JOHN L

CIK 00012160747 companiesJUPITER, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001216074

Recent Transactions

50 trades

Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2026-06-10$247.22/sh−257→ 31,303 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2026-06-10$248.11/sh−232→ 31,071 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2026-06-10$249.53/sh−697→ 30,374 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2026-06-10$251.62/sh−3,405→ 26,969 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2026-06-05+836→ 31,560 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2026-06-05+2,938→ 2,938 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2026-03-06−2,161→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2026-03-06$114.15/sh+2,161→ 32,885 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2026-03-06$200.76/sh−2,161→ 30,724 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-11-07$69.51/sh+2,034→ 32,758 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-11-07$205.45/sh−2,034→ 30,724 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-11-07$205.45/sh−2,145→ 30,724 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2025-11-07−2,145→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2025-11-07−2,034→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-11-07$66.13/sh+2,145→ 32,869 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-06-06+1,209→ 30,724 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2025-06-06+5,783→ 5,783 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-11-27$123.65/sh−2,406→ 29,515 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2024-11-27−2,406→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-11-27$52.30/sh+2,406→ 31,921 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-06-14+1,252→ 29,515 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2024-06-14+5,444→ 5,444 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2023-06-09+1,142→ 28,263 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2023-06-09+5,461→ 5,461 total
Award
Immunome Inc.$IMNM
Stock Option (Right to Buy)
2023-06-08+6,500→ 6,500 total
Award
Immunome Inc.$IMNM
Common Stock
2023-01-15$4.00/sh+15,125→ 66,953 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2022-12-22+4,484→ 4,484 total
Award
Immunome Inc.$IMNM
Stock Option (Right to Buy)
2022-06-16+6,500→ 6,500 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2022-06-10+4,340→ 4,340 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2022-06-10+1,004→ 26,402 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2021-11-16−4,835→ 0 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2021-11-16$161.86/sh−4,835→ 25,398 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2021-11-16$32.30/sh+4,835→ 30,233 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2021-06-04+630→ 25,398 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2021-06-04+3,269→ 3,269 total
Award
Immunome Inc.$IMNM
Stock Option (Right to Buy)
2021-05-28+3,750→ 3,750 total
Purchase
Immunome Inc.$IMNM
Common Stock
2021-05-24$18.58/sh+5,102→ 51,828 total
Purchase
Immunome Inc.$IMNM
Common Stock
2021-05-24$18.44/sh+338→ 46,726 total
Award
Immunome Inc.$IMNM
Stock Option (Right to Buy)
2020-11-03+7,500→ 7,500 total
Conversion
Immunome Inc.$IMNM
Warrant (right to buy)
2020-10-06−11,111→ 0 total
Conversion
Immunome Inc.$IMNM
Series A Convertible Preferred Stock
2020-10-06−46,388→ 0 total
Conversion
Immunome Inc.$IMNM
Warrant (right to buy)
2020-10-06+11,111→ 11,111 total
Conversion
Immunome Inc.$IMNM
Common Stock
2020-10-06+46,388→ 46,388 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2020-06-10+2,468→ 2,468 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2020-06-10+831→ 24,768 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2019-08-01$95.58/sh−847→ 23,937 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2019-08-01−2,500→ 4,835 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2019-08-01$32.30/sh+2,500→ 24,784 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2019-06-26+27,000→ 27,000 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2019-06-06+4,071→ 4,071 total

Companies

Recent Filings

Address

555 HERITAGE DRIVE SUITE 200

JUPITER, FL, 33458

View on SEC.gov